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Abstract
Background: Genetic variation in folate metabolism has been associated with survival in utero, the success of in
vitro fertilisation, multiple pathologies and longevity.
Methods: We have looked at the prevalence of genetic variants of the enzymes MTHFR and TYMS in 2,898 DNA
samples derived from five cohorts collected in the United Kingdom. The simultaneous analysis of genetic variants
of the MTHFR and TYMS loci was carried out to investigate a putative gene-gene interaction that was first observed
in an elderly male population from Norfolk.
Results: We have made a consistent observation in five population cohorts; the proportion of individuals who are
homozygous for the 2R allele of the 5’UTR TYMS polymorphism is less in individuals who are homozygous for the
T allele of MTHFR 677 than in individuals homozygous for the C allele of MTHFR 677 (p = 0.02).
Conclusions: These data may suggest a gene-gene interaction and could be evidence of genetic selection, with
some pregnancies more or less viable as a consequence of genetic variation. If these genetic phenomena affect
the way folate is handled at the cellular level in utero it is possible that maternal folic acid intake may over-ride
such genetic selection.
Background
Folate-dependent one-carbon metabolism is essential for
nucleotide synthesis, methionine synthesis and for DNA
methylation and depends on a number of enzymes that
are functionally polymorphic. SNPs and other poly-
morphisms of the genes MTHFR, MTRR and TYMS
have been associated with cardiovascular disease, neural
tube defects, Down syndrome and leukaemia [1-4]. Ade-
quate dietary folate, and its efficient metabolism have
well-established roles in disease prevention; deficiency is
associated with increased risk of neural tube defects,
vascular disease, cancer and anaemia [5].
Proposals for the mandatory fortification of flour with
folate in the United Kingdom are driven by the impor-
tance of this B vitamin to the development of the early
embryo [6]. Embryo development and viability has been
the subject of many epidemiological studies of genetic
variants, including, and possibly predominantly, in those
genes involved in folate metabolism [2-4,7]. B-vitamin
status and folate metabolism have been shown to influ-
ence the outcome of in vitro fertilisation (IVF) [8,9].
Women who are homozygous for a variant of the gene
MTHFR (1298A>C) were less likely to produce a live-
b i r t ht h a no t h e rw o m e nu n d e r g o i n gI V Fa n dt h e
chances of a twin birth increased with plasma and red
cell folate concentrations [8]. The authors proposed that
the woman’s genotype is linked to her potential to pro-
duce good quality embryos and that this, coupled with
folate status, increases the likelihood of IVF resulting in
live births. Haggarty et al also observed an association
between raised concentrations of homocysteine and an
increase in the risk of miscarriage in their study of
women undergoing IVF and elevated homocysteine
levels has been linked recurrent pregnancy loss pre-
viously [10].
A meta-analysis has demonstrated that maternal
hyperhomocysteinaemia (a metabolic consequence of
low folate status) is associated with orofacial cleft and
congenital heart defects [11], but the authors found no
independent association between these congenital mal-
formations and MTHFR genotype in either the mothers
or children. However, the negative in utero effect of
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Yates as one of the mechanisms by which the genetic
variant, MTHFR 677C>T, compromises the viability of a
pregnancy when dietary folate levels are inadequate [12].
These authors also hypothesise that when folate levels
are unrestricted, there is a survival advantage in utero
for homozygotes for the 677C>T allele because that
genotype will increase the levels of 5,10 methylene tetra-
hydrofolate favouring DNA synthesis and stability. This
hypothesis is supported by the authors of a recent study
of the prevalence of this genotype in adult populations
and in DNA samples taken from spontaneous abortions,
they present evidence for the selection of the 677C>T
allele associated with increased folate intake by women
in the peri-conceptional period [13].
The MTHFR 677C>T variant is associated with
raised homocysteine concentrations and lower enzyme
concentrations [14]. Association studies of the MTHFR
677C>T variant and adverse pregnancy outcomes have
in the main concluded that this variant is important in
the pathogenesis of adverse pregnancy outcomes [15].
Less compelling evidence is available for TYMS genetic
variants [16], one of which is a 5’UTR repeat variant
(2R/3R) and the rare 2R variant is associated with
lower TYMS expression and plasma homocysteine
[17]. The simultaneous analysis of multiple genetic var-
iants allows the consideration of additive, synergistic
and compensating variants of folate metabolism. Dis-
ease association studies of two or more enzyme var-
iants of folate metabolism are few, but suggest the
possibility of gene-gene interactions or epistasis. One
study has demonstrated a multiplicative effect on phe-
notype for the MTHFR 677C>T and MTRR 66G>A
genotype combinations in relation to Down syndrome
[4]. Another study demonstrated that three genotype
combinations of the loci MTRR/FOLH1; MTHFR 677/
CBS and MTHFR 677/MTRR increase the risk of
neural tube defects [7].
A functional study of MTHFR and TYMS has shown
that these enzymes compete for limiting supplies of
folate required for homocysteine methylation [17];
which illustrates the likelihood that certain steps in one-
carbon metabolism present bottlenecks for the distribu-
tion of folate species, and enzyme variants in these steps
may be important.
We and others have previously found evidence for
depletion of individuals homozygous for MTHFR
677C>T relative to younger cohorts, and postulated it to
be due to genotype-specific survival [18-20]. Because of
observations made in cross-sectional population studies
to explore the impact of genetic variants of the enzymes
MTHFR and TYMS on survival in elderly cohorts, we
have studied the prevalence of two polymorphisms in
younger populations. The MTHFR and TYMS loci are
found on chromosomes 1 and 18 respectively so linkage
disequilibrium will not explain any digenic phenomena
observed.
Methods
Subjects
The polymorphic locus MTHFR 677C>T and the 5’UTR
repeat variant of TYMS (2R/3R) were co-analysed in 2,898
DNA samples from the following 5 population cohorts.
Cohort 1
DNA extracted from 1178 blood samples collected from
an elderly male population undergoing full blood counts
in primary care or as patients at the Norfolk and Nor-
wich University Hospital. Mean age = 84 years [range
70-99 years].
Cohort 2
DNA extracted from 438 blood samples collected from
an elderly female population undergoing full blood
counts in primary care or as patients at the Norfolk and
Norwich University Hospital. Mean age = 92 years
[range 89-104 years].
Cohort 3
DNA was extracted from 409 blood samples collected
from a young female population undergoing full blood
counts in primary care or as patients at the Norfolk and
Norwich University Hospital. Mean age = 27 years
[range 18-40 years].
Cohort 4
DNA was analysed from 398 blood samples from appar-
ently healthy male volunteers recruited through a local
community media-advertising campaign for a genetic
and iron homeostasis study [21]. Mean age = 60 years
[range 40-80 years]. The MTHFR data from this cohort
has been described previously [22].
Cohort 5
DNA was obtained from 475 female volunteers from
North Cumbria Community Genetics Project (NCCGP)
[23]. Mean age of whole NCCGP cohort = 28 years
[range 16-44 years].
Genotyping
DNA extraction and genotyping
High molecular weight DNA was sub-aliquoted onto 96
well plates at a concentration of approximately 100 ng/
μl. All subsequent reactions were also performed in 96
well plates. The PCR reactions comprised of 100 ng
DNA, 200 nmol/L of each primer and 1 × PCR Thermo
Start Mastermix (ABgene UK, Epsom, England) in a 25
μl volume. The PCR conditions for each assay are
shown in table 1.
The MTHFR assay required restriction digestion prior
to gel electrophoresis. 10 μlo fP C Rp r o d u c tw a s
digested overnight at 37°Cina20 μl reaction volume. The
enzyme and buffer used (New England Biolabs, Hitchin,
UK) are described in table 1.
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Tris/Borate/EDTA, 3% Metaphor agarose (FMC Biopro-
ducts, Lichfield, UK) gel in a stretch-wide apparatus
(ABgene, Epsom, UK) at 80 V for 50 minutes.
Quality assurance
G e la n a l y s i sd a t aw e r es c r e e n e di n d e p e n d e n t l yb yt w o
scientists (GW, BJ) and approximately 10% of the samples
were genotyped a second time to check for concordance.
A duplication of the MTHFR genotyping for 264 samples
showed 100% concordance. A duplication of the TYMS
genotyping for 362 samples showed 99.2% concordance
and resulted in 3 reassigned genotypes. Furthermore, 4
samples that carried the rare 4 repeat allele were excluded
from the analysis. The overall success rate for genotyping
(in primary genotyping and re-analyses) was 99.6% for the
MTHFR locus and 97.2% for the TYMS locus.
The samples from cohorts 1 to 4 were also genotyped
for MTHFR 1298 (rs1801131) and found to be in complete
linkage disequilibrium with MTHFR 677 as expected.
Statistics
Hardy-Weinberg equilibrium (HWE); The c
2-test was
used to analyse the frequencies of genotypes detected
for each locus and relative fitness ratios were estimated
for homozygotes compared to heterozygotes.
We tested the hypothesis that the proportion of indi-
viduals homozygous for the 2R allele of the 5’UTR
TYMS polymorphism was lower in the group homozy-
gous for the T allele of MTHFR 677 than in the group
homozygous for the C allele of MTHFR 677 using a
one-sided Fisher’s exact test for each population. We
used Stouffer’s consensus combined P-value test, as
described and recommended in Rice (1990), which is
designed to combine the P-values from a set of indepen-
dent tests addressing the same hypothesis [24].
Ethics
Ethical approval for the study of anonymised DNA sam-
ples of groups 1 to 4 was obtained from Norwich and
Waveney LREC. Ethical approval for the study of group
5 was obtained from Leeds West MREC.
Results
Genotyping
We have simultaneously determined the MTHFR 677
and TYMS 5’UTR genotype frequencies using DNA
samples from 5 population cohorts comprising 2,898
individuals. The prevalence data and deviations from
HWE are described in table 2 in addition to the relative
fitness ratios for homozygotes compared to heterozy-
gotes. Data are only presented for those samples that
were successfully genotyped at both loci and which car-
ried either the 2R or 3R allele at the TYMS locus.
We observed that the proportion of individuals who
are homozygous for the TYMS 2R allele is different in
the two groups of homozygotes for the MTHFR 677; the
proportion of individuals who are homozygous for the
2R allele of the 5’UTR TYMS polymorphism in indivi-
duals with the C>T allele of MTHFR 6 7 7i sl e s st h a n
the proportion of individuals who are homozygous for
the 2R allele in homozygotes for the C allele of MTHFR
677 (see figure 1). We first made this observation in the
elderly Norfolk cohorts 1 and 2. Therefore, to test if this
observation was a real phenomenon, we analysed the
MTHFR and TYMS genotypes in new populations and
subsequently made the same observation in Norfolk
cohorts 3 and 4 and in cohort 5, the female volunteers
from North Cumbria Community Genetics Project [23].
The observations were consistent in all populations
studied.
Statistics
We found for all populations tested that the proportion
of individuals who are homozygous for the TYMS 2R
allele was lower in the TT homozygotes for MTHFR
677 than the CC homozygotes, but the individual tests
were not significant (Table 3). The consensus combined
p-value test [23] was significant (p = 0.02). Removing
Table 1 Description of PCR Assays
GENE
SNP I.D. or description
MTHFR
rs1801133
TYMS
5’UTR
EX1+52CCGCGCCACTTC
GCTGCCTCCGTCCCC
Rare allelic form
(amino acid changes)
677C>T (A222V) 2R
[17]
Sense primer and antisense primer GGGTCAGAAGCATATCAGTCATG
CACAAAGCGGAAGAATGTGTC
AAAAGGCGCGCGGAAG
GCCGGCCACAGGCAT
Annealing temperature, cycle number 55°C, 38 cycles 61°C, 38 cycles
PCR product size in base pairs 326 111 or 139
Restriction enzyme (number of units) or size of ins/del Hinf I (0.2), buffer 2 28 bp repeat visible by gel electrophoresis
Fragment sizes for common allele in base pairs.
Fragment sizes for rare allele in base pairs.
104 and 222
102, 166 and 53
139
111
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lysis, the consensus p-value was still significant (p =
0.04) for cohorts 3, 4 and 5 only.
Discussion
We have observed a consistent gene-gene interaction in
5 different cohorts. Certain genotypes are differentially
represented in these populations and this could be evi-
dence of genetic selection during early development; in
gamete formation or in utero, with some gametes or
pregnancies more or less viable because of variation in
the way folate is handled at the cellular level, the meta-
bolism of folate being the link between these enzymes
and their genetic loci.
There is published evidence for significant genome-
wide transmission distortion [25] which could be caused
by genetic and/or environmental influences on gamete
selection and embryo viability. Ebisch et al demon-
strated that sperm concentration can be raised with folic
acid and zinc sulphate supplementation, but only in
males who are homozygous for the 677C genotype [26].
Lucock and Yates have hypothesised that when folate
levels are unrestricted, there is a survival advantage in
utero for homozygotes for the 677C>T allele because
that genotype will increase the levels of 5,10 methylene
tetrahydrofolate favouring DNA synthesis and stability
[12]. The investigations by Mayor-Olea et al found that
the wild type, 677CC, genotype is almost absent in
spontaneous abortions suggesting that this genotype
may protect against pregnancy loss. However, they also
interpret the increase in the prevalence of the T allele
alongside the use of peri-conceptional folic acid as an
indication that an environmental factor can lead to the
Table 2 The MTHFR and TYMS genotype distributions, relative fitnesses and deviations from HWE of the genotypes in
the 5 populations from Norfolk and Cumbria
MTHFR CC CT TT Relative fitness
CC vs CT
Relative fitness
TT vs CT
Deviation from HWE
Cohort 1 Observed 486.0 564.0 128.0 0.92 0.85 0.063
Expected 500.7 534.6 142.7
Cohort 2 Observed 206.0 191.0 41.0 0.98 0.95 0.824
Expected 207.5 187.9 42.5
Cohort 3 Observed 179.0 178.0 52.0 1.06 1.11 0.445
Expected 175.6 184.8 48.6
Cohort 4 Observed 166.0 202.0 30.0 0.81 0.61 0.003
Expected 179.1 175.8 43.1
Cohort 5 Observed 185.0 214.0 76.0 1.08 1.13 0.287
Expected 179.5 225.0 70.5
TYMS 3_3 2_3 2_2 Relative fitness
3_3 vs 3_2
Relative fitness
2_2 vs 3_2
Deviation from HWE
Cohort 1 Observed 350.0 541.0 287.0 1.16 1.18 0.007
Expected 326.8 587.3 263.8
Cohort 2 Observed 126.0 216.0 96.0 1.02 1.01 0.848
Expected 125.0 218.0 95.0
Cohort 3 Observed 129.0 180.0 100.0 1.24 1.28 0.022
Expected 117.3 203.5 88.3
Cohort 4 Observed 124.0 184.0 90.0 1.14 1.16 0.189
Expected 117.2 197.6 83.2
Cohort 5 Observed 146.0 240.0 89.0 0.96 0.94 0.641
Expected 149.0 234.1 92.0
Observed and expected genotype frequencies and deviations from HWE were calculated from the prevalence data for the MTHFR 677 and TYMS 5’UTR loci in
2898 samples that were simultaneously genotyped at both loci
Figure 1 Differences in distributions of the TYMS 2R_2R
homozygous genotype for each of the homozygous MTHFR
genotypes.
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of deleterious genotypes [13].
Our observation could not be caused by any simple gen-
otyping error because the relationship observed between
MTHFR and TYMS is independent of heterogeneity in the
allele frequencies for the individual polymorphisms
between the cohorts. During t h ec o u r s eo ft h e s ee x p e r i -
ments we investigated the possibility of technical artefacts
because it can be seen from table 2 that some of the indi-
vidual gene frequencies were out of HWE (see MTHFR
frequency for cohort 4 and TYMS frequencies for cohorts
1 and 3) and genotyping errors could explain this. Undi-
gested PCR product in the analysis of the MTHFR 677
polymorphism, and preferential amplification of the TYMS
allele with 2 rather than 3 repeats could produce erro-
neous data for the individual genotypes. Although only a
single laboratory assay was used for each genotype analy-
sis, the DNA quality and data interpretation checks
described in the methods provide confidence in the repro-
ducibility of our methods. Futhermore, while genotyping
errors could result in perturbation of HWE they would
not generate the significant co-segregation of MTHFR and
TYMS genotypes described.
Deviation from HWE is also possible if there are
selective advantages for particular genotypes. A selective
advantage for particular MTHFR genotypes could lead
to deviations from HWE in the general population; het-
erozygote advantage occurs when environmental situa-
tions lead to heterozygous individuals for some disease
alleles having increased fitness over both homozygous
genotypes. In the older cohorts (1, 2 and 4) in this study
both homozygous groups showed a reduced fitness rela-
tive to the heterozygotes for MTHFR 677 (see table 2).
We and others have previously found evidence for
depletion of individuals homozygous for the MTHFR
677C>T relative to younger cohorts, and postulated it to
be due to genotype-specific fatal disease [18-20,24].
However, given that the interaction between MTHFR
and TYMS is found in all age groups, this interaction
cannot be interpreted as an age-related survival factor; i.
e. the death of some individuals from genotype-specific
fatal disease does not explain the observation.
Given that all of the subjects from our study were
born before the influence of folate related public
health initiatives, could B-vitamin supplementation
affect the biological phenomena that we and others
have described? Haggarty et al report that folic acid
intervention has not resulted in genetic selection in
favour of the MTHFR 677T allele [27], however this
does not take into account potential gene-gene interac-
tions at other folate-related loci and does not discount
the possibility that numerous genetic variants may act
in concert to exert selective pressure.
Conclusions
Our data may suggest a gene-gene interaction and could
be evidence of genetic selection, with some pregnancies
more or less viable as a consequence of genetic varia-
tion. If these genetic phenomena affect the way folate is
handled at the cellular level in utero it is possible that
maternal folic acid intake may over-ride such genetic
selection. Our findings should now be tested in indepen-
dent population cohorts.
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